论文部分内容阅读
目的 :分析用甲泼尼龙辅助治疗慢性阻塞性肺病(COPD)的效果。方法 :将我院收治的120例COPD患者随机分为试验组与对照组,每组各60例患者。为对照组患者进行常规治疗,在此基础上为试验组患者加用甲泼尼龙进行治疗,然后对比观察两组患者的临床疗效。结果 :与对照组患者相比,试验组患者治疗的总有效率较高,差异显著(P<0.05),有统计学意义。与对照组患者相比,试验组患者在进行治疗后其凝血酶原时间、动脉血氧分压及血氧饱和度均得到明显的改善,差异显著(P<0.05),有统计学意义。结论 :在为急性加重期COPD患者采取常规疗法的基础上为其加用甲泼尼龙进行治疗可取得理想的效果,能显著缓解其临床症状,改善其肺功能,此法值得在临床上推广应用。
Objective: To analyze the effect of methylprednisolone in the treatment of chronic obstructive pulmonary disease (COPD). Methods: A total of 120 COPD patients admitted to our hospital were randomly divided into experimental group and control group, 60 cases in each group. For the control group of patients with conventional treatment, on the basis of the test group plus methylprednisolone treatment, and then compared the clinical efficacy of two groups of patients. Results: Compared with the control group, the total effective rate of the treatment group was significantly higher (P <0.05), which was statistically significant. Compared with the control group, the prothrombin time, arterial partial pressure of oxygen and saturation of oxygen saturation were significantly improved in the test group after treatment, with significant difference (P <0.05). CONCLUSIONS: Based on the conventional therapies for COPD patients with acute exacerbations, the addition of methylprednisolone can achieve the desired effect, relieve the clinical symptoms and improve the pulmonary function, which is worthy of clinical application .